SOPHiA GENETICS

About:

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Website: https://www.sophiagenetics.com

Twitter/X: SOPHiAGENETICS

Top Investors: Eurazeo, Generation Investment Management, Hitachi Ventures, Perceptive Advisors, Balderton Capital

Description:

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

Total Funding Amount:

$265M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)sophiagenetics.com

Founders:

Jurgi Camblong, Lars Steinmetz, Pierre Hutter

Number of Employees:

251-500

Last Funding Date:

2024-05-02

IPO Status:

Public

© 2024 MyAiNote.com